| 发明名称 |
NOVEL SOLUBLE CTLA4 VARIANTS |
| 摘要 |
The present invention provides novel soluble CTLA4 variant compositions useful for intervening T cell mediated activities. The compositions are useful in therapies for immune system disorders such as autoimmune diseases, inflammatory disorders and transplant rejections. |
| 申请公布号 |
WO2013041029(A1) |
申请公布日期 |
2013.03.28 |
| 申请号 |
WO2012CN81635 |
申请日期 |
2012.09.20 |
| 申请人 |
IGENIMED PHARMACEUTICALS INC. |
发明人 |
LI, QING |
| 分类号 |
C07K14/435;A61K39/395;A61K47/18;A61P35/00;C07K14/705;C12N15/12;C12N15/63 |
主分类号 |
C07K14/435 |
| 代理机构 |
|
代理人 |
|
| 主权项 |
|
| 地址 |
|
